WITHDRAWN ARTICLE: Effect of Sesame Lignan Supplementation on Carotid Intima-Media Thickness, Serum Lipid Profile, Serum VEGF, VCAM-1, ICAM-1 and vWF Levels in Cardiovascular Disease Patients.

Abstract

Background: Atherosclerosis is a chronic inflammatory disease of the vascular wall which can alter the whole vascular system of both the aorta and coronary arteries. Sesame seeds are one of the richest sources of dietary lignans which exhibit diverse functions and valuable effects such as anti-hypertensive, anti-inflammatory, and anti-oxidative activities. Objectives: In this study, the Effect of sesame lignans on carotid intima-media thickness (CIMT), serum lipid profile, and serum levels of VEGF, VCAM-1, ICAM-1 and vWF were evaluated in cardiovascular (CVD) patients. Methods: In this double-blind, randomized, placebo-controlled clinical trial, thirty-six CVD patients who were candidates for angiography participated for 10 weeks. The subjects were asked to use 500 mg/day sesame lignans (lignan group, n = 19) or placebo (placebo group (starch), n = 17). The CIMT was measured by ultrasound and fasting blood samples were taken before and after the intervention. Results: Sesame lignans supplementation showed a significant decrease in both left and right CIMT, serum lipid profile, fasting blood glucose, and ICAM-1 serum levels compared to baseline and placebo (P < 0.05). Conclusions: These findings indicate that sesame lignans may contribute to the reduction of CIMT and prevent future cardiovascular events and so may be considered as a complementary therapeutic approach in CVD